Abbott reduces board size from 13 to 12, effective April 28, 2023

ABBOTT LABORATORIES

Board approved amendment to Article III, Section 2 of by-laws on Feb 17, 2023.
Board size reduced from 13 to 12 directors, effective April 28, 2023.
Amended by-laws filed as Exhibit 3.1 to the Form 8-K.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ABBOTT LABORATORIES: Board of Directors size changed from 13 to 12 persons, effective April 28, 2023 (effective 2023-04-28).

Change: bylaw amendment
Effective: 2023-04-28

Exact text from the filing

Abbott’s Board of Directors amended the first sentence of Article III, Section 2 of Abbott’s by-laws to provide that Abbott’s Board of Directors shall consist of twelve persons, effective April 28, 2023.

View on SEC.gov

Browse all governance changes →

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR

accession 0001104659-23-023291

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.